Medtronic wins FDA nod for Resolute Onyx drug-eluting stent

Medtronic (NYSE:MDT) said today that the FDA approved its Resolute Onyx drug-eluting stent.
The Fridley, Minn.-based company touted its device as the 1st stent formed by a sinusoidal wave of cobalt alloy wire. The company incorporated a radiopaque inner core within the wire to boost visibility, according to Medtronic. The stent also features thin struts and a polymer blend that minimizes inflammation and risk of stent thrombosis.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic wins FDA nod for Resolute Onyx drug-eluting stent appeared first on MassDevice.

Source: Mass Device - May 1, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Drug-Eluting Stents Food & Drug Administration (FDA) Vascular Wall Street Beat Medtronic Source Type: news